This inventor holds 3 USPTO granted patents and 7 published patent applications. Top assignee: Biojiva LLC. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Peter Milner: Innovator in ALS Treatment
Introduction
Peter Milner is a notable inventor based in Los Altos, California. He has made significant contributions to the field of medicine, particularly in the treatment of amyotrophic lateral sclerosis (ALS). His innovative approach combines various therapeutic methods to inhibit the progression of this debilitating disease.
Latest Patents
Milner holds a patent for a synergistic combination therapy for treating ALS. The patent discloses methods for inhibiting the progression of ALS in humans. The methods utilize a synergistic combination of methyl-phenyl-pyrazoline-one and deuterated arachidonic acid or a prodrug thereof, such as 11,11-D2-linoleic acid or an ester thereof. This innovative therapy represents a promising advancement in ALS treatment.
Career Highlights
Peter Milner is associated with Biojiva LLC, where he continues to work on groundbreaking research and development in the field of ALS treatment. His dedication to improving patient outcomes through innovative therapies is commendable.
Collaborations
Milner collaborates with talented individuals such as Nadia Litterman and Mark Midei. Their combined expertise contributes to the advancement of research and development in ALS therapies.
Conclusion
Peter Milner's work in developing a synergistic combination therapy for ALS showcases his commitment to innovation in medicine. His contributions have the potential to significantly impact the lives of those affected by this challenging condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile